COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,696 Articles (22,913 medRxiv, 8,783 bioRxiv)

Most recent first Previous |  Page 292: Articles 2911-2920  | Next

Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Roederer, A. L., Cao, Y., St. Denis, K., Sheehan, M. L., Li, C. J., Lam, E. C., Gregory, D. J., Poznansky, M. C., Iafrate, A. J., Canaday, D. H., Gravenstein, S., Garcia-Beltran, W. F., Balazs, A. B.
10.1101/2024.03.05.24303815 — Posted: 2024-03-07
Contact behaviour before, during and after the COVID-19 pandemic in the Netherlands: evidence from contact surveys in 2016-2017 and 2020-2023
Backer, J. A., Vos, E. R. A., den Hartog, G., van Hagen, C. C. E., de Melker, H. E., van der Klis, F. R. M., Wallinga, J.
10.1101/2024.03.06.24303851 — Posted: 2024-03-07
Community level variability in Bronx COVID-19 hospitalizations associated with differing viral variant adaptive strategies during the second year of the pandemic.
Forster, R. M., Griffen, A., Daily, J., Kelly, L.
10.1101/2024.03.05.24303791 — Posted: 2024-03-07
Estimating the impact of public health interventions on COVID mortality in the United States using reductions in influenza mortality as an indicator of non-pharmaceutical infection control
Morris, R. D.
10.1101/2024.03.06.24303834 — Posted: 2024-03-07
Coronavirus Nucleocapsid Protein Enhances the binding of p-PKCα to RACK1: Implications for Inhibition of Nucleocytoplasmic Trafficking and Suppression of the Innate Immune Response
Liao, Y., Xue, W., Chu, H., Wang, J., Sun, Y., Qiu, X., Song, C., Tan, L., Ding, C.
10.1101/2024.03.06.583677 — Posted: 2024-03-07
Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models
Mahmud, M. S., Kadelka, C., Gonzalez-Parra, G.
10.1101/2024.03.04.24303726 — Posted: 2024-03-06
Amino acid profiling of COVID-19 patients blood serum
Russkikh, Y., Sushentseva, N., Popov, O., Apalko, S., Shimansky, V. S., Asinovskaya, A., Mosenko, S., Sarana, A., Scherbak, S.
10.1101/2024.03.05.24303773 — Posted: 2024-03-06
XBB.1.5 mRNA COVID-19 Vaccination and Inpatient or Emergency Department Visits Among Adults Infected with SARS-CoV-2 JN.1 and XBB-Lineage Variants
Levy, M. E., Chilunda, V., Heaton, P. R., McKeen, D., Goldman, J. D., Davis, R. E., Schandl, C. A., Glen, W. B., McEwen, L. M., Cirulli, E. T., Wyman, D., Dei Rossi, A., Dai, H., Isaksson, M., Washington, N. L., Basler, T., Tsan, K., Nguyen, J., Ramirez, J., Sandoval, E., Lee, W., Lu, J., Luo, S.
10.1101/2024.03.05.24303796 — Posted: 2024-03-06
Stress vulnerability and resilience in children facing COVID-19-related discrimination: a quasi-experimental study using polygenic, brain, and sociodemographic data
Yi, J., Lee, E., Kim, B.-G., Kim, G., Joo, Y. Y., Cha, J.
10.1101/2024.03.04.24303643 — Posted: 2024-03-06
Cause-Specific Excess Mortality in the US During the COVID-19 Pandemic
Degtiareva, E., Tilstra, A., Schoeley, J., Dowd, J. B.
10.1101/2024.03.05.24303783 — Posted: 2024-03-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).